Baicalin is one of the main flavonoids of the dried root of Scutellaria baicalensis Georgi and is reported to exert beneficial effects on the regulation of glucose/lipid metabolism. However, understanding its specific target and unique mechanism for improving glucose utilization is a challenge. In this paper, target fishing with a baicalin probe reveals that baicalin interacts with AKT. An immunofluorescence assay further demonstrates the colocalization of baicalin with AKT in the cytoplasm. A competitive test and virtual docking show that baicalin might bind to the pleckstrin homology domain of AKT. This specific binding hampers AKT membrane translocation, activates the phosphorylation of AKT on Ser473, induces the downstream glycogen synthase kinase 3b activation, and affects glycogen synthesis.
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Keywords: AKT; baicalin; glucose metabolism; GSK3b; PH domain Diabetes is a chronic metabolic disorder in which blood glucose levels are abnormally elevated (hyperglycemia) [1] , and it has long been a major disease that harms human health [2] . Insulin resistance results in damage to the tissues of the liver, muscles, fat, and other tissues involved in the regulation of blood glucose metabolism and plays a key role in type 2 diabetes (T2D) [3] [4] [5] . For a long time, the link between insulin resistance, obesity, and T2D has been investigated [6] .
AKT, also known as PKB (protein kinase B), is a Ser/Thr kinase, is an important node protein of the insulin signaling pathway and the phosphatidylinositol 3-kinase (PI3K) signaling pathway. AKT is mainly expressed in insulin-responsive tissues involved in the regulation of glucose homeostasis [7, 8] . The modular structure of AKT consists of a C-terminal regulatory domain, an N-terminal pleckstrin homology (PH) domain, and a kinase catalytic domain in the middle [7] [8] [9] . The products of PI3K activation, PIP3 and its immediate decomposition product PIP2, both trigger physiological processes by interacting with proteins having a PH domain [10] . One of the characterized PIP3/PIP2 effector proteins is the AKT protein [11] . AKT plays a pivotal role in insulin resistance [12, 13] , and the relationship between the suppression of the PI3K-AKT signaling pathway and diabetes is mostly concentrated [14, 15] . The PI3K-AKT signaling pathway regulates the expression of gluconeogenesis genes and fatty acid synthesis genes by regulating the activity Abbreviations AKT, PKB (protein kinase B); BDP, boron dipyrromethene fluorophore; DMEM, Dulbecco's modified Eagle's medium; FSA, fluorescentlabeled anti-rabbit IgG secondary antibodies; GSK3b, glycogen synthase kinase 3b; LiCl, lithium chloride anhydrous; Met, metformin hydrochloride; MMs, magnetic microspheres; PH domain, pleckstrin homology domain; PIP2, PtdIns(3,4)P2; PIP3, PtdIns (3, 4, 5) 
of downstream molecules, such as forkhead box protein O1 (FOXO1) and glycogen synthase kinase 3b (GSK3b). Hence, the activation of AKT is the integral result of multiple inputs to regulate glucose utilization and lipid metabolism [6] .
Baicalin is one of the most valid and abundant flavonoid component extracts in the roots of Scutellaria baicalensis, with antidiabetic and neuro-protective activities and anti-inflammatory and antidyslipidemic properties [16] [17] [18] [19] . In a previous report, Guo et al. [20] found that baicalin inhibited p38 and NF-jB phosphorylation to suppress the proinflammatory cytokines IL-b, IL-6, and TNF-a. In addition, Fang et al. [21] found that baicalin activated the AKT/AS160/GLUT4 pathway to combat against obesity and insulin resistance. Recently, chemo proteomics research reveals that baicalin ameliorates obesity and hepatic steatosis by activating hepatic CPT1 [22] . Furthermore, it is reported that baicalin possesses the ability to prevent skeletal muscle ectopic fat storage and insulin resistance by regulating the AKT/GSK3b pathway [23] . Although the benefits of baicalin in the regulation of glucose metabolism have been confirmed, the underlying target and mechanism of the hypoglycemic effect of baicalin are not clear yet.
In this study, we tried to identify the targets of baicalin by integrated chemical biology methods. For clarifying the key target protein on insulin resistance pathways, a novel alkynyl-modified baicalin probe was synthesized and used for target capture and cell localization in HepG-2 cells. A set of ligand-competitive tests and virtual docking experiments were utilized to obtain a binding pocket of the target protein. After a membrane transport test and downstream signaling pathway evaluation, the potential molecular mechanism of how baicalin improves glucose metabolism through the insulin and PI3K/AKT signaling pathways was revealed. 
Materials and methods

Reagents
Synthesis of the alkynyl-modified baicalin probe
Di-succinimidyl carbonate (688 mg, 2.688 mM) was added to a solution of baicalin (400 mg, 0.896 mM) and pyridine (0.433 mL, 5.376 mM) in 25 mL of dichloromethane, and it was stirred overnight at room temperature. After completion of the reaction, 50 mL of dichloromethane was added for extraction, and the organic layer was washed with 20 mL of HCl (1 M), 20 mL of NaHCO 3 (saturation), and 20 mL of saturated brine, in that order, and then, the organic layer was collected as a yellow solid, which was the crude intermediate. This crude product and N,N-Diisopropylethylamine (178 lL, 1.075 mM) were dissolved in 20 mL of N,N-Dimethylformamide, and propargylamine (59.2 lL, 1.075 mM) was added slowly under ice-cooling and was slowly warmed to room temperature under argon protection overnight, as shown in Fig. S1 . To obtain an alkynylmodified baicalin probe (yellow solid), the mixture was centralized in vacuo and was purified by column chromato-graphy on a silica gel (dichloromethane : methanol = 10 : 1). The yield of this reaction was 67% (290 mg). In the supporting information, the detailed NMR data are included ( Fig. S2 and the (-)-HR-ESI-MS spectrum of alkynyl-baicalin is shown in Fig. S3 ).
Target prediction of baicalin
To predict the protein target of baicalin, a pharmacophore matching platform PharmMapper was utilized. 
Target fishing
The HepG-2 cells were cultured with DMEM complete medium for 24 h in 75-cm 2 culture flasks. Subsequently, the cells were washed with a precooled PBS solution three times, and 0.5 mL of RIPA lysis buffer (China COSCO, Beijing, China) was added for 30 min on ice followed by collection with a cell scraper. Then, the lysate (at 4°C) was centrifuged at 15 450 g for 10 min. The lysate was centrifuged (15 450 g) for 10 min at 4°C, and the bicinchoninic acid protein assay kit (Thermo Scientific, Waltham, MA, USA) was used to quantify the supernatant. The protein concentration was adjusted to 1 mgÁmL À1 in precooled hypotonic buffer. After that, the baicalin-modified functionalized MMs (see Figs S4 and S5 for details) were added. The mixture was incubated at 4°C with gentle shaking overnight. After collecting by magnetic separation, the MMs were rinsed with precooled PBST three times. The proteins bound by baicalin were released by incubation with 200 lL of DTT (100 mM) for 30 min at 4°C, and the supernatants were gathered for SDS/PAGE and the western blot analysis.
Colocalization in cells
The HepG-2 cells were cultured at a suitable density in glass bottom dishes, and they were treated with or without an alkynyl-modified baicalin probe (10 lM) for 6 h when the cells reached approximately 60% confluence. After washing, the treated cells were fixed in 4% paraformaldehyde for 15 min and then they were washed with PBST three times. Next, the cells were blocked with 5% goat serum for 1 h and were incubated with an anti-AKT antibody (1 : 200) at 4°C overnight. Then, they were treated with fluorescent-labeled anti-rabbit IgG secondary antibodies (FSA; Alexa Fluor Ò 594) for 1 h at 37°C. After washing with PBST three times, the fixed cells were taken through the biorthogonal click reaction with 100 lL of BDP reaction solution (10 lM BDP TMR azide, 20 lM Tris-triazoleamine, 10 lM CuSO 4 , and 20 lM sodium ascorbate) at room temperature for 1 h. After an adequate number of washes, the fluorescence images were obtained with a confocal microscope (Leica TCS SP8, Oskar Barnack, Germany). The excitation and emission wavelengths for FSA (Alexa Fluor Ò 594) were employed at 594 and 617 nm and for BDP TMR azide they were employed at 514 and 570 nm, respectively.
SDS/PAGE and western blot analysis
The SDS/PAGE (10%) was conducted using a general protocol. Briefly, the cells were washed with precooled PBS two times and were lysed with RIPA lysis buffer for 30 min on ice. The cell lysates were centrifuged at 15 450 g for 15 min at 4°C to obtain the supernatants. The supernatants or the captured protein were mixed with loading buffer, were boiled and were loaded for SDS/PAGE and Coomassie Blue staining if necessary. The other SDS/PAGE gel was transferred to a PVDF membrane for a western blot analysis. After transfer, the membrane was blocked with 5% skim milk for 1 h and was incubated with a primary antibody (1 : 1000) overnight at 4°C. After rinsing with PBST, the membrane was then incubated with a secondary antibody (1 : 2500) at room temperature for 1 h. After adequate washing, the membranes were incubated with chemiluminescent HRP substrates and were exposed in a Tanon-5200 Chemiluminescence Apparatus (Shanghai, China). The relative optical densities of the bands were quantified using the free software IMAGEJ (NIH, Bethesda, MD, USA).
Competitive test
The fresh mouse liver was homogenized and was placed in RIPA lysis buffer at a rate of 1 gÁmL À1 and was gently ground and lysed on ice for 30 min. Then, the lysate was centrifuged (12 000 r.p.m.) for 10 min at 4°C. The target protein capture process by the baicalin-modified functionalized MMs was the same as the above target fishing process, except the last protein release step. As a positive control group, the enriched proteins were released with 200 lL of DTT, just as described in the above section. In the competition groups, the captured AKT proteins were competed with 200 lL of different 10 lM competitors (SC79, AKT inhibitor VIII, AT7876 and PHT-427) at 4°C for 30 min. Similarly, the released proteins in the supernatants were collected for AKT detection by a western blot.
AKT plasma translocation assay
To detect the AKT translocation effects, the HEK293-transiently transfected cell lines expressing the AKT PH-GFP or AKT PH(R25C)-GFP fusion proteins were generated. The HEK293 cells were plated in a glass bottom dish for 24 h. Subsequently, transfection of the two plasmids was performed separately (the ratio of the poly(ethylenimine) to plasmid mass was 6 : 1), and the transfection time was 6 h. Prior to transfection, the cells were incubated with DMEM cultures that solubilized SC79, baicalin or baicalein to prevent the overexpression of the AKT PH-GFP membrane translocation. Subsequently, the GFP images were captured with a spectral-type AF7000 Live Cell Imaging System (Carl Zeiss, Oberkochen, Germany). The excitation and emission wavelengths of GFP were set as 488 and 507 nm, respectively.
Enzymatic activity assay
The HepG-2 cells were plated in 75-cm 2 culture flasks and were cultured with DMEM complete medium for 24 h. Then, the cell lysates were prepared as described in the above section. Afterward, the lysates were divided into several equal parts of 100 lL each. They were the control group, baicalin group (0.1, 1, and 10 lM) and positive drug group, which included SC79 (10 lM) as an agonist of the AKT enzyme activity and LiCl (10 lM) as an inhibitor of GSK3b enzyme activity. After synchronization, each group was bathed in a 37°C water bath for 45 min. Then, the enzymatic activities of the AKT and GSK3b in cell lysates were quantified as described in the manufacturer's manual (GENMED, Arlington, MA, USA).
Glucose consumption assay
The HepG-2 cells were grown in 96-well culture plates at a density of 2 9 10 4 cells per well. After 24 h of incubation, the culture medium was replaced by the serum-free medium with or without 1 lM insulin for the next 24 h. Then, the cells in the different treatment groups were treated with baicalin or Met (10 lM) for another 12 h. Then, the supernatants were collected for the glucose concentration assay using the glucose assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) based on glucose oxidase method, according to the manufacturer's instructions.
Statistical analysis
The results are reported as the means AE standard deviations (SD). The statistical analysis was performed using PRISM 5.01 (GraphPad Software, San Diego, CA, USA). For single comparisons, significant differences between the means were determined using a Student's t test. The significance was accepted as P < 0.05.
Results and Discussion
Identification of AKT as a target of baicalin
To capture the target protein of baicalin from the cells, an alkynyl-modified baicalin probe was synthesized as a tracer. Then, the baicalin-modified functionalized MMs were prepared by a click reaction in vitro, according to the scheme shown in Fig. 1A . Next, the functionalized MMs were used to capture the protein target in the HepG-2 cells, and the disulfide bond between the MMs and baicalin probe was broken by DTT to release the captured proteins. To identify the target proteins of baicalin, SDS/PAGE and Coomassie brilliant blue staining were performed to evaluate the collecting efficiency. As shown in the left panel of Table S1 . The String10.5 analysis was performed to determine the inner linkage among the selected proteins. As shown in Fig. 1C , the top five pathways (based on the q value) were the insulin signaling pathway (red), the PI3K-AKT signaling pathway (blue), the prolactin signaling pathway (yellow), prostate cancer (green), and the Rap1 signaling pathway (purple) ( Table S2 ). Analyzing these pathways suggested that the insulin signaling pathway [25] and the PI3K-AKT signaling pathway [26] were the most related to glucose and lipid metabolism. In addition, previous reports of baicalin-regulated glucose metabolism and insulin resistance mainly focus at these two signaling pathways [21, 27] .
By analyzing the relationship between the five pathways, AKT1 and HRAS were the most important nodes and were speculated as two potential targets of baicalin. To confirm the hypothesis, we performed a western blot validation via the captured proteins. The same SDS/PAGE gel was transferred to PVDF membranes for the western blot analysis. As shown in Fig. 1B on the right, the total protein from the HepG-2 lysate, shown in Lane 1, detected AKT1 and HRAS. Compared with Lane 1, the lysate enriched by the baicalin-modified MMs was defined as Lane 3, and AKT was accurately captured while Ras was not. Based on this result, we speculated that AKT may be one of the key targets of baicalin in regulating glucose metabolism.
Colocalization with AKT in the cells
To explore the interaction between baicalin and AKT, the click reaction between the BDP TMR azide fluorochrome and the baicalin probe was carried out (Fig. 2A) . As shown in Fig. 2B , the conjugate ring in the click product shows a strong green fluorescence that is clearly observed in the cytoplasm, and the red fluorescence of FSA (Alexa Fluor Ò 594) reflects the distribution of AKT. The untreated baicalin probe showed little fluorescence in the control group. The distribution of AKT (red) was also observed in the cytoplasm and partially merged (yellow) with the baicalin probe. These results suggested that AKT proteins might be the target of baicalin under cellular conditions.
Baicalin binds to the PH domain of AKT
As mentioned, the modular structure of AKT consists of the PH domain, the kinase catalytic domain, and the regulatory domain [8] . To verify the binding pocket of AKT with baicalin, we designed a competition experiment. A set of AKT ligands (SC79, PHT-427, AKT VIII, and AT7876) were chosen to compete with AKT, which were captured by the baicalinmodified functionalized MMs. SC79 is a specific AKT PH domain inhibitor that targets the PH domain of AKT, which in turn activates AKT [28] . PHT427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 PH domain inhibitor, inhibits the activity of AKT [29] . AT7867 is an ATP-competitive inhibitor, which competes with ATP at the ATP-binding site and inhibits the activity of AKT [30] . AKT VIII is reported as an allosteric inhibitor of AKT kinase, which will also restrict the activity of AKT [31] . As shown in Fig. 3A , the results showed that both the agonist (SC79) and antagonist (PHT-427) of the PH-binding domain of AKT specifically competed with the baicalin-bound probe, which was similar to the positive group that released AKT after DTT reduction. This result indicated that baicalin might combine with the AKT PH domain.
As a natural ligand of the AKT PH domain, PIP3 binds to the PH domain of AKT in a shallow pocket. It is then mediated by several salt bridges between the phosphate groups and basic residues in the protein [28] . 4IP is a known ligand for the AKT PH domain, and it lacks only long-chain hydrocarbons for the membrane hang compared to PIP3. It is known that the activation of PI3K converts PIP2 to PIP3, instead of PIP2 binding to the AKT PH domain, and the hydrogen bond interactions at Lys14, Arg25, and Arg86 of the AKT PH are regarded as the key amino residues, which are closely related to membrane translocation [32] . In addition, the other amino acid residues, such as Arg23 and Asn53, are also reported to be important. The interaction of Arg23 with the D1 phosphate plays a role in regulating the overall affinity of AKT for 3-phosphoinositides. Additionally, a slight reduction in the binding is observed for the Asn53 mutation (which interacts with the D3 and D4 phosphates). As shown in Fig. 3B , the molecular docking of MOE for the AKT PH domain demonstrated that SC79, baicalin and 4IP bound with the key amino acids Asn53 (N53) and Arg25 (R25). A previous study showed that Arg25 in the AKT PH domain sequence is essential for AKT's binding ability with 4IP (third carbon atom at inositol). If Arg25 is inhibited or mutated, AKT cannot be translocated to the plasma membrane [32] .
It is reported that AKT translocation to the plasma membrane promotes its phosphorylation to sustain Fig. 4 . Baicalin affects the activity of AKT and GSK3b by acting on the phosphorylation of AKT itself and its downstream signaling, improving glucose metabolism. (A) Western blots showing the phosphorylation levels of the AKT upstream and downstream effectors of PDK1, AKT (Thr308 and Ser473), and GSK3b, which were treated with different doses of baicalin. GAPDH expression was used as an internal control for normalization. Each bar represents the mean AE SD. *P < 0.05 and **P < 0.01 vs. Con group (n = 3). (B, C) The enzymatic activity of AKT and GSK3b in the HepG-2 cells lysate after treatments with different concentrations of baicalin. SC79 and LiCl were used as positive controls for AKT and GSK3b activity detection, respectively. Each bar represents the mean AE SD. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. Con group (n = 3). (D) Effect of baicalin with different concentrations on glucose consumption in the insulin-treated HepG-2 cells. Met served as a positive control. Each bar represents the mean AE SD. ## P < 0.01 vs. Con group; *P < 0.05 and **P < 0.01 vs. Mod group (n = 6).
AKT activity [33] . To investigate whether baicalin has the same effect on the direct activation of AKT as SC79, GFP-tagged AKT PH domains were used to follow the subcellular localization of AKT in HEK293 cell lines. After transfecting with the respective plasmids for 6 h, two kinds of fusion proteins, namely, AKT PH-GFP and AKT PH(R25C)-GFP, were generated. Among these, AKT PH(R25C)-GFP was a positive control because its AKT PH-GFP protein cannot be translocated to the membrane under the stimulation of insulin-like growth factor 1 (IGF1) [31] . The expressed AKT PH-GFP fusion protein was a tracer that was used to detect and evaluate the AKT plasma membrane translocation phenomenon.
After transfection, IGF-1 (10 lM) was used to stimulate the cells for 10 min, and the induction of AKT PH membrane translocation occurred. Compared with the IGF-1-induced AKT PH membrane translocation effect in the AKT PH-GFP-HEK 293 cells, baicalin inhibited the occurrence of AKT PH's translocation to the membrane in a dose-dependent manner, just as SC79 did (Fig. 3C) .
Baicalein is an aglycone metabolized form baicalin. Once absorbed into the body, baicalein undergoes extensive first-pass glucuronidation to glucuronide conjugates, such as baicalin, in both the liver and intestine [34, 35] . Molecular docking showed that the carboxy group from the D-glucuronic acid of baicalin, which bound with Arg25 and Arg23 (Fig. 3B) , occupied the PIP3-binding active pockets near the Arg25, inhibited the interaction between the phosphoryl group of PIP3 and Arg25, and reduced the transmembrane activity of AKT (Fig. 3C) . When baicalein lost the D-glucuronic acid from the baicalin, it did not impact the transmembrane function of AKT (Fig. 3C) .
Baicalin promoted glucose consumption by inducing the phosphorylation of AKT and GSK3b
The activation of AKT enhances glycogen synthesis via the direct phosphorylation and inhibition of GSK3 [36] . Phosphorylated GSK3b activates a number of intracellular signaling pathways, including glucose metabolism, the regulation of cell differentiation, and cell survival [37, 38] . The increased phosphorylation of GSK-3b protein also contributes to insulin resistance by affecting glycogen synthesis [39] .
To evaluate the effect of baicalin on AKT activation, the upstream and downstream protein expression levels of AKT in the PDK1/AKT/GSK3b axis were examined after treated baicalin for 1 h. As shown in Fig. 4A , baicalin does not change the phosphorylation level of PDK1, but the amount of AKT phosphoprotein (only in Ser473 not Thr308) is upregulated in a dose-dependent manner. For the downstream proteins, baicalin also upregulated the phosphorylation of GSK3b. Further exploration of the enzyme activity testified that baicalin increased the enzyme activity of AKT and deactivated GSK3b, as shown in Fig. 4B ,C. Activated AKT phosphorylated and deactivated GSK-3b, leading to the activation of glycogen synthesis and downregulating the blood glucose level (Fig. 4D) .
Baicalin-induced AKT activation
The activation of AKT, by the regulation of phosphorylation, is caused by the PIP3-mediated plasma membrane translocation. It is reported that PIP3 not only phosphorylates AKT but also induces conformational changes in AKT, promoting AKT phosphorylation [28, [40] [41] [42] . The AKT1/2 isoforms contain two regulatory phosphorylation sites at Ser473 in the C-terminal of the kinase domain (EXT domain) and Thr308 in the activation loop (chloramphenicol acetyltransferase domain) [43] . Normally, the conformational change in AKT exposes the phosphorylation sites and promotes the phosphorylation and activation of AKT, and at the same time, it is demonstrated that chemically induced cytoplasmic AKT allosteric activation bypasses the need for AKT membrane recruitment [28] .
The deactivation of AKT contributes insulin resistance in type 1 and 2 diabetes. Under these pathological conditions, elevating AKT activity becomes an obvious clinical strategy for inhibiting insulin resistance [28] . In the absence of PIP3, AKT is in the off-inactivated state, and the binding of PIP3 to the PH domain makes it a more favorable conformation to release this intramolecular constraint. The baicalin-induced AKT conformation change that is favorable for the phosphorylation site at Ser473 may act similarly to PIP3. It activates AKT in the cytosol and bypasses the PIP3-mediated AKT membrane translocation requirements (Fig. 5) .
In conclusion, our research suggested that baicalin enhanced glucose metabolism by targeting the critical activation site of the AKT PH domain. Although AKT membrane translocation is hampered, its phosphorylation at S473 activates downstream proteins, such as GSK3b, contributing to insulin resistance via affecting glycogen synthesis. The approach presented in this paper suggests that directly activating the AKT PH PIP3-binding pocket may have considerable potential in the regulation of metabolic diseases, and also provides insights for the development of AKT agonists for treating insulin resistance.
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